Want to see HNGE full AI Analyst Report?
HNGE Stock Chart & Stats
$74.31
$1.40(1.88%)
At close: 4:00 PM EDT
$74.31
$1.40(1.88%)
Day’s Range― - ―
52-Week Range$30.08 - $91.50
Previous Close$36.79
Volume368.85K
Average Volume (3M)2.05M
Market Cap
$5.78B
Enterprise Value$6.54K
Total Cash (Recent Filing)$389.39M
Total Debt (Recent Filing)$5.88M
Price to Earnings (P/E)―
Beta1.52
Next Earnings
Nov 03, 2026EPS Estimate
0.63Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.35
Shares Outstanding54,655,926
10 Day Avg. Volume1,732,427
30 Day Avg. Volume2,053,901
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)9.72
Price to Sales (P/S)6.26
P/FCF Ratio21.54
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$99.33Price Target Upside33.67% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)2.6
Revenue Forecast (FY)$822.13M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue Growth & Billings MomentumConsistent high-single- to double-digit organic growth and 52% LTM billings growth provide a durable demand signal from employers and plans. Strong billings act as a leading indicator for revenue conversion, underpinning multi-quarter visibility into sales cadence and capacity to scale commercial operations.
High Gross Margins & Strong Cash GenerationVery high gross margins driven by care-team efficiency and automation, paired with rapidly improving free cash flow, imply durable unit economics. Strong FCF supports reinvestment in product, clinical studies and sales, while reducing dependence on external financing for growth and strategic M&A.
Conservative Balance Sheet & Capital FlexibilityLow leverage and sizable cash/equity provide financial flexibility to fund product expansion, acquisitions and buybacks without stressing liquidity. Conservative capital structure reduces solvency risk and gives management optionality to prioritize strategic investments or return capital over the medium term.
Bears Say
GAAP Earnings Volatility / Large 2025 LossA massive 2025 GAAP loss contrasts with cash generation, signaling major non-cash charges, one-offs or scaling costs that cloud normalized profitability. Persistent earnings volatility complicates forecasting, could pressure investor confidence, and raises questions about sustainable long-term return on invested capital.
Growth Reliant On Yield ImprovementsIf revenue upside depends on extracting more revenue per eligible life (yield) rather than broad expansion of eligible lives or ASP, durable growth requires sustained engagement, referrals and renewals. Those operational levers are execution-sensitive and vulnerable to competitive pressure, client churn or shifting utilization patterns.
Cylinder Acquisition Integration & Concentration RiskAcquiring a small, less-mature GI player creates near-term integration costs and execution risk. Concentrated Cylinder revenues and a modest near-term contribution mean benefits may take many quarters to materialize, potentially pressuring margins and diverting management focus during the integration window.
Hinge Health, Inc. Class A News
HNGE FAQ
What was Hinge Health, Inc. Class A’s price range in the past 12 months?
Hinge Health, Inc. Class A lowest stock price was $30.08 and its highest was $91.50 in the past 12 months.
What is Hinge Health, Inc. Class A’s market cap?
Hinge Health, Inc. Class A’s market cap is $5.78B.
When is Hinge Health, Inc. Class A’s upcoming earnings report date?
Hinge Health, Inc. Class A’s upcoming earnings report date is Nov 03, 2026 which is in 89 days.
How were Hinge Health, Inc. Class A’s earnings last quarter?
Hinge Health, Inc. Class A released its earnings results on Aug 04, 2026. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.615 by -$0.025.
Is Hinge Health, Inc. Class A overvalued?
According to Wall Street analysts Hinge Health, Inc. Class A’s price is currently Undervalued.
Does Hinge Health, Inc. Class A pay dividends?
Hinge Health, Inc. Class A does not currently pay dividends.
What is Hinge Health, Inc. Class A’s EPS estimate?
Hinge Health, Inc. Class A’s EPS estimate is 0.63.
How many shares outstanding does Hinge Health, Inc. Class A have?
Hinge Health, Inc. Class A has 54,655,926 shares outstanding.
What happened to Hinge Health, Inc. Class A’s price movement after its last earnings report?
Hinge Health, Inc. Class A reported an EPS of $0.59 in its last earnings report, missing expectations of $0.615. Following the earnings report the stock price went up 1.725%.
Which hedge fund is a major shareholder of Hinge Health, Inc. Class A?
Currently, no hedge funds are holding shares in HNGE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hinge Health, Inc. Class A Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$99.33 (33.67% Upside)
$99.33 (33.67% Upside)
Blogger Sentiment
Bullish
HNGE Sentiment 83%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $212.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.4%
Last 30 Days ▲ 5.5%
Last 30 Days ▲ 5.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
61.61%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.28%
Trailing 12-Months
Company Description
Hinge Health, Inc. Class A
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
HNGE Company Deck
HNGE Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a strongly positive operational and financial story: high top-line growth (+53% Q2 revenue), substantial billings momentum (+52% LTM billings), marked margin and free cash flow expansion (operating margin +1,000 bps YoY; free cash flow 3x YoY), raised guidance, and concrete product/TAM expansion (Migraine traction and the $105M Cylinder acquisition to enter GI). Key risks are manageable near-term execution items — integrating Cylinder, some non-recurring margin tailwinds (tariff refund), reliance on continued yield improvements for upside, and heightened competitive noise. Overall, the positives (growth, profitability, cash generation, product traction, and clinical evidence) materially outweigh the near-term integration and concentration risks.View all HNGE earnings summariesHNGE Stock 12 Month Forecast
Average Price Target
$99.33
▲(33.67% Upside)
Technical Analysis
Ownership Overview
8.46% Insiders
19.52% Mutual Funds
3.25% Other Institutional Investors
56.10% Public Companies and
Individual Investors